Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FLEP9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,234
Award facts
- Contract value 100% obligated
- $10,233.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,233.54 delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Dupixent 300 mg/2 mL pens with an ultimate completion date of July 9, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order falls within AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which encompasses a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities supporting military and veteran healthcare systems globally. Dupixent (dupilumab) is a biologic medication used primarily for treating moderate-to-severe atopic dermatitis and other inflammatory conditions, reflecting the contractor's extensive portfolio of specialty pharmaceutical products supplied to the Department of Defense healthcare network. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania and registered in SAM.gov, continues to serve as a critical vendor for federal medical procurement through its established relationship with the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FLEP9?
SPE2DB25FLEP9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 8, 2025.
How much is contract SPE2DB25FLEP9 worth?
The government has obligated $10,234 on SPE2DB25FLEP9.
Is contract SPE2DB25FLEP9 an order under another contract?
Yes. SPE2DB25FLEP9 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB25FLEP9 competed?
The extent of competition for SPE2DB25FLEP9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award